Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Ariel D. Stern"'
Publikováno v:
npj Digital Medicine, Vol 6, Iss 1, Pp 1-5 (2023)
Abstract Digital Health Technologies (DHTs) such as connected sensors offer particular promise for improving data collection and patient empowerment in neurology research and care. This study analyzed the recent evolution of the use of DHTs in trials
Externí odkaz:
https://doaj.org/article/fd9f7e10c5774d039719f8d4652d9f90
Publikováno v:
npj Digital Medicine, Vol 5, Iss 1, Pp 1-4 (2022)
Abstract Rapid innovation and proliferation of software as a medical device have accelerated the clinical use of digital technologies across a wide array of medical conditions. Current regulatory pathways were developed for traditional (hardware) med
Externí odkaz:
https://doaj.org/article/6995ad0f27764874a4608057977eefeb
Autor:
Anna Essén, Ariel D. Stern, Christoffer Bjerre Haase, Josip Car, Felix Greaves, Dragana Paparova, Steven Vandeput, Rik Wehrens, David W. Bates
Publikováno v:
npj Digital Medicine, Vol 5, Iss 1, Pp 1-10 (2022)
Abstract An abundant and growing supply of digital health applications (apps) exists in the commercial tech-sector, which can be bewildering for clinicians, patients, and payers. A growing challenge for the health care system is therefore to facilita
Externí odkaz:
https://doaj.org/article/047490c3647a4b2bacc1b3988173dd84
Publikováno v:
npj Digital Medicine, Vol 3, Iss 1, Pp 1-6 (2020)
Abstract Reimbursement is a key challenge for many new digital health solutions, whose importance and value have been highlighted and expanded by the current COVID-19 pandemic. Germany’s new Digital Healthcare Act (Digitale–Versorgung–Gesetz or
Externí odkaz:
https://doaj.org/article/699020c339bf4f678ee7d556e451e821
Publikováno v:
npj Digital Medicine, Vol 3, Iss 1, Pp 1-5 (2020)
Abstract Over recent years, the adoption of connected technologies has grown dramatically, with potential for improving health care delivery, research, and patient experience. Yet, little has been documented about the prevalence and use of connected
Externí odkaz:
https://doaj.org/article/d302a71ada7d4260aa9bc550a7a5d606
Publikováno v:
npj Digital Medicine, Vol 4, Iss 1, Pp 1-3 (2021)
From clinical trials to care delivery, advanced, digitally enabled technologies and analytics offer new approaches to how we think about medicine, health, and biology. The Covid-19 pandemic has accelerated this conversation, and forced a roadmap, onc
Externí odkaz:
https://doaj.org/article/dcf2352235364d2ba2c98b21a22e7359
Publikováno v:
Health Affairs. 41:1248-1254
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a003ee5def4d56f75f00f6bcc270c25a
https://doi.org/10.1377/hlthaff.2021.02026
https://doi.org/10.1377/hlthaff.2021.02026
Publikováno v:
JAMA. 329:1609
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de74c9f0cfa341e7b2db3afe8837e81c
https://doi.org/10.1001/jama.2023.4095
https://doi.org/10.1001/jama.2023.4095
Autor:
Anna Essén, Ariel D. Stern, Christoffer Bjerre Haase, Josip Car, Felix Greaves, Dragana Paparova, Steven Vandeput, Rik Wehrens, David W. Bates
Publikováno v:
Essen, A, Stern, A D, Haase, C B, Car, J, Greaves, F, Paparova, D, Vandeput, S, Wehrens, R & Bates, D W 2022, ' Health app policy : international comparison of nine countries' approaches ', npj Digital Medicine, vol. 5, no. 1, 31 . https://doi.org/10.1038/s41746-022-00573-1
npj Digital Medicine
npj Digital Medicine, 5(1):31, 1-10. Nature Publishing Group
npj Digital Medicine
npj Digital Medicine, 5(1):31, 1-10. Nature Publishing Group
An abundant and growing supply of digital health applications (apps) exists in the commercial tech-sector, which can be bewildering for clinicians, patients, and payers. A growing challenge for the health care system is therefore to facilitate the id
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::169f11438d992ccf913e8280483323f1
https://curis.ku.dk/ws/files/301624913/Health.pdf
https://curis.ku.dk/ws/files/301624913/Health.pdf
Publikováno v:
JAMA. 329:144
ImportanceMost regulated medical devices enter the US market via the 510(k) regulatory submission pathway, wherein manufacturers demonstrate that applicant devices are “substantially equivalent” to 1 or more “predicate” devices (legally marke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d9a1b799caeed1ab6eb739ff40d15e2
https://doi.org/10.1001/jama.2022.22974
https://doi.org/10.1001/jama.2022.22974